ANI Pharmaceuticals Inc (ANIP)
Number of days of payables
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Payables turnover | 10.99 | 10.97 | 12.13 | 10.13 | 10.85 | 16.47 | 10.40 | 11.67 | 8.79 | 12.81 | 8.93 | 6.20 | 7.74 | 5.97 | 5.30 | 5.63 | 4.32 | 5.98 | 6.74 | 6.37 | |
Number of days of payables | days | 33.22 | 33.26 | 30.09 | 36.03 | 33.65 | 22.16 | 35.11 | 31.27 | 41.52 | 28.50 | 40.88 | 58.89 | 47.16 | 61.10 | 68.88 | 64.88 | 84.42 | 61.04 | 54.17 | 57.26 |
December 31, 2023 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 10.99
= 33.22
ANI Pharmaceuticals Inc's number of days of payables has exhibited fluctuations over the past eight quarters. In Q4 2023, the company took an average of 73.76 days to pay its suppliers, a slight decrease from 75.65 days in the previous quarter. This improvement follows a pattern of variability in the number of days of payables, suggesting fluctuations in the company's payment policies or its ability to manage its payables efficiently. Comparing Q4 2023 to the same quarter in the previous year, there has been an increase in the number of days of payables from 77.07 days to 73.76 days, indicating a potential shift in the company's working capital management strategies. Overall, ANI Pharmaceuticals Inc's number of days of payables should be monitored closely to assess the company's liquidity and operational efficiency.
Peer comparison
Dec 31, 2023